Cellab CDMO

how-we-work

About

CGT CDMO

Cellab CDMO is a Contract Development and Manufacturing Organization (CDMO) specialized in cell and gene therapy. Our team has a decade of expertise in ATMP manufacturing and GMP processes. We are specialized in collaborating closely with small teams to develop ATMPs from basic research to clinical trials and commercialization.

We partner closely with our clients, acting as an extension of their team to accelerate the journey from bench to bedside. Our agile approach allows us to adapt quickly to evolving project needs, ensuring timely delivery and success. With a focus on quality, integrity, and innovation, we are committed to delivering excellence in every aspect of ATMP development.

How we work

We make it easy

Cellab CDMO provides top-tier collaboration services, guaranteeing GMP compliance across the entire drug development.

By working closely with our clients and adopting a flexible and collaborative approach, we ensure a successful and less risky outcome for your ATMP development project.

From bench to the clinic

We’ve built a dedicated process development team committed to fit your specific requirements.

Our aim is to navigate you from your present state to your envisioned future set up, offering tailored solutions to align with your objectives within a structured timeline, spanning from R&D to GMP production of your ATMP.

diagrama cellab

Services

Tailored made services

We offer a broad range of services, tailored made and highly adaptable to the clients need. It includes bioprocess scaling design from R&D to GMP, ATMP manufacturing, GMP batch release, GMP storage area, among others.

Manufacturing, Science, and Technologies (MS&T)

▪️ Transition from Early-stage. developments to GMP manufacturing.
▪️ Hands-on partnership, working closely with your team.
▪️ A full team for skilled aseptic operators with years of expertise in biologic manufacturing.

GMP and GMP-Like Manufacturing

▪️ Cell Therapy.
▪️ Gene Therapy.
▪️ Aseptic Fill&Finish.

Quality Control and characterization

▪️ Flow cytometry.
▪️ Cell counter and viability.
▪️ Endotoxin Ph. Eur. 2.6.14.
▪️ Sterility tests – Ph.Eur.2.6.1 & Ph.Eur.2.6.27.
▪️ Mycoplasma test Ph. Eur 2.6.7.
▪️ Potency assays

GMP storage area

▪️ RT: 20-25ºC.
▪️ Refrigeration: 2-8ºC.
▪️ Freeze and ultra-freeze: -20ºC and -80ºC.
▪️ Cryopreserved: -150ºC.

Logistic assistance, including Import/Export

▪️ UE batch release.
▪️ Regulatory assistance.
▪️ Global transportation and brokerage capabilities.

Why choose Cellab CDMO?

WE ARE VERSATILE

Our customer proximity model allows you to work alongside our technical team.

EXPERIENCED EXPERTS

We have a complete team with deep understanding of GMP requirements and regulatory standards.

ENHANCING QUALITY, REDUCING COSTS

Our efficient processes and economies of scale allow to offer cost-effective services

END-TO-END SERVICE

From biological starting material sourcing to UE batch release.

Facilities

Facilities designed for your projects

Cellab CDMO owns and operates GMP-licensed facilities that are designed for cell and gene therapy manufacturing. All rooms are fully equipped with best-in-class equipment to manufacture autologous and allogeneic therapies. Our facilities provide the space and equipment needed to conduct early-stage development and GMP manufacturing.
Previous
Next

Team

Who we are

Our team of experienced and enthusiastic professionals bring a deep understanding of GMP requirements, regulatory standards, and industry best practices to every project we undertake. Discover more about this dynamic group who are poised to facilitate the journey of your therapy.
Alex Marfany

Alexandre Marfany Pluchart

Chief Executive Officer
BSc in Business Administration.

More than 5 years of experience managing different companies.

Alex joins Cellab as CEO in 2020.
Alba Casamayor

Alba Casamayor Genescà, PhD

Chief Operating Officer & Head of QC
BSc in Biotechnology, MSc in Advanced Biotechnology and PhD in Biotechnology.

More than 15 years of experience in ATMPs research and manufacturing under GMP together with QC, cells and tissue banc management in AABB standards.

Alba joins Cellab in 2013.
JUAN JESÚS BANDERA

Juan Jesús
Bandera

Chief Business Officers
BSc in Economy. MSc in Health Economics and Health Care Business Administration

More than 20 years of experience in health research management at GM/C suite level. Extensive expertise in early phases clinical trials with ATMPs as well as managing manufacturing sites.

Juan Jesús joins Cellab in 2024.
Raquel Calderon

Raquel Calderon Almendro, PhD

Chief Quality & Compliance Officer
BSc in Pharmacy, MSc in Pharmaceutical Industry and PhD in Biomedical Chemistry.

More than 10 years of experience in pharmaceutical industry, QA and QP positions under GMP.

Raquel joins Cellab in 2021.
Clara Boces

Clara Boces Pascual, PhD

Chief R&D integration and GMP Development
BSc in Biology, MSc in Biomedicine and PhD in Biomedicine.

10 years of experience in Research and Development in the field of Biomedicine and process development of GMP Biological Therapies.

Clara joins Cellab in 2020.

Claudia Pujol Bonaparte

Chief Manufacturing Officer & Head of Production
BSc in Chemistry and MSc in Pharmaceutical Industry.

More than 10 years of experience in biological banc samples under AABB standards, together with processing and manufacturing ATMPs under GMP.

Claudia joins Cellab in 2016.
Joan Muro

Joan Muro De Sas

Chief Marketing Officer
BSC in Journalism. MSc in Master of Business Administration in ESADE

More than 10 years of experience in sales and marketing.

Joan joins Cellab in 2017.

Paul Starz

Business Developer
BSc in Chemistry and Biochemistry. MSc in Biochemistry, major on Biomedicine.

5 years of experience in research, business development, patent management. Focused on Cell Therapy and immunology.

Paul joins Cellab in 2024.

Join us

Be part of a team of experts dedicated to ATMPs. Know the vacant positions and send your application!

Contact

Let’s talk!

Advanced Therapies Made Easy
©2024 Cellabcdmo. All rights reserved
Cookie Policy | Legal Notice | Privacy Policy